Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMATOPROST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS vs BIMATOPROST: Safety Overview

Metric BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS BIMATOPROST
Total FAERS Reports 176 14,752
Deaths Reported 0 74
Death Rate N/A 0.5%
Hospitalizations 110 245
Average Patient Age 66.0 yrs 62.3 yrs
% Female Patients 91.7% 77.6%
FDA Approval Date N/A Apr 12, 2019
Manufacturer N/A Gland Pharma Limited
Route N/A OPHTHALMIC
Marketing Status N/A Discontinued